
|Articles|April 1, 2004
The American Journal of Managed Care
- April 2004
- Volume 10
- Issue 4
Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC
2
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
3
Physical Activity, Vaccination May Protect Against Long COVID
4
Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations
5